Back
Adaptimmune Therapeutics PLC Stock Price Chart
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
37
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.21
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- The current trend is relatively stagnant and ADAP is experiencing slight buying pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Buy |
| 20-day SMA: | 1.16 | Buy |
| 50-day SMA: | 1.37 | Sell |
| 200-day SMA: | 0.9 | Buy |
| 8-day EMA: | 1.11 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 1.08 | Buy |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 49.21 | Sell |
| Chaikin Money Flow: | -64850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.42) | Sell |
| Bollinger Bands (100): | (0.72 - 1.46) | Buy |
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.19 while ADAP 8-day simple moving average is 1.08, which is a Buy signal.
- The stock price of ADAP is 1.19 while Adaptimmune Therapeutics PLC 20-day SMA is 1.16, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 1.37 while ADAP share price is 1.19, making it a Sell technically.
- ADAP stock price is 1.19 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.90, creating a Buy signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
37
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.19. The Score for ADAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
292.73M
Price in USD:
1.19
Share Volume:
648.5K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
37
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 1.19 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.19 while ADAP 8-day exponential moving average is 1.11, which is a Buy signal.
- The stock price of ADAP is 1.19 while Adaptimmune Therapeutics PLC 20-day EMA is 1.16, which makes it a Buy.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 1.22 while ADAP share price is 1.19, making it a Sell technically.
- ADAP stock price is 1.19 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.08, creating a Buy signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 49.21, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (1.04 - 1.42), which suggest Adaptimmune Therapeutics PLC is a Buy
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.72 - 1.46), which suggest Adaptimmune Therapeutics PLC is a Buy
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.